Mitral valve cardiac restoration system PASCAL

Mitral regurgitation: Treatment is complex and options are limited Mitral regurgitation (MR) occurs in approximately 2% of the population, with up to 10% of people over 75 years old affected1 Optimised leaflet capture Empowering delivery system with direct manoeuvring in 3 planes Independent leaflet capture Effective Designed for effective MR reduction Broad paddles maximize leaflet coaptation Central spacer fills the regurgitant orifice area Safe Excellent safety profile Spacer & contoured paddle design reduce stress on leaflets Implant elongation helps promote safe subvalvular manoeuvring For professional use For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions, and adverse events. Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity. Material for distribution only in countries with applicable health authority product registrations. Material not intended for distribution in USA or Japan. Edwards, Edwards Lifesciences, the stylized E logo, PASCAL, and Cardioband are trademarks of Edwards Lifesciences .Corporation or its affiliates. All other trademarks are the property of their respective owners.